Age-related immune response heterogeneity to SARS-CoV-2 vaccine BNT162b2
Open Access
- 30 June 2021
- journal article
- research article
- Published by Springer Science and Business Media LLC in Nature
- Vol. 596 (7872), 417-422
- https://doi.org/10.1038/s41586-021-03739-1
Abstract
Although two-dose mRNA vaccination provides excellent protection against SARS-CoV-2, data are scarce on vaccine efficacy against variants of concern (VOC) in individuals above 80 years of age1. Here we analysed immune responses following vaccination with mRNA vaccine BNT162b22 in elderly participants and younger health care workers. Serum neutralisation and binding IgG/IgA after the first vaccine dose diminished with increasing age, with a marked drop in participants over 80 years old. Sera from participants above 80 showed significantly lower neutralisation potency against B.1.1.7, B.1.351 and P.1. variants of concern as compared to wild type and were more likely to lack any neutralisation against VOC following the first dose. However, following the second dose, neutralisation against VOC was detectable regardless of age. Frequency of SARS-CoV-2 Spike specific B-memory cells was higher in elderly responders versus non-responders after first dose. Elderly participants demonstrated clear reduction in somatic hypermutation of class switched cells. SARS-CoV-2 Spike specific T- cell IFNγ and IL-2 responses decreased with increasing age, and both cytokines were secreted primarily by CD4 T cells. We conclude that the elderly are a high risk population that warrant specific measures to boost vaccine responses, particularly where variants of concern are circulating.Keywords
Other Versions
This publication has 27 references indexed in Scilit:
- Safety and Immunogenicity of SARS-CoV-2 mRNA-1273 Vaccine in Older AdultsThe New England Journal of Medicine, 2020
- Combined Point-of-Care Nucleic Acid and Antibody Testing for SARS-CoV-2 following Emergence of D614G Spike VariantCell Reports Medicine, 2020
- CoV-AbDab: the coronavirus antibody databaseBioinformatics, 2020
- A thermostable, closed SARS-CoV-2 spike protein trimerNature Structural & Molecular Biology, 2020
- Single-shot Ad26 vaccine protects against SARS-CoV-2 in rhesus macaquesNature, 2020
- Measuring SARS-CoV-2 neutralizing antibody activity using pseudotyped and chimeric virusesThe Journal of Experimental Medicine, 2020
- Why the elderly appear to be more severely affected by COVID‐19: The potential role of immunosenescence and CMVReviews in Medical Virology, 2020
- Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort studyBMJ, 2020
- Immune senescence, epigenetics and autoimmunityClinical Immunology, 2018
- Impact of Aging and Cytomegalovirus on Immunological Response to Influenza Vaccination and InfectionFrontiers in Immunology, 2017